| scholarly article | Q13442814 |
| P50 | author | Olav Spigset | Q64158961 |
| Nils Erik Gilhus | Q65250964 | ||
| P2093 | author name string | Anne Kjersti Daltveit | |
| Bettina Riedel | |||
| Marte Helene Bjørk | |||
| Elisabeth Synnøve Nilsen Husebye | |||
| P2860 | cites work | High dose folic acid supplementation in women with epilepsy: are we sure it is safe? | Q27025031 |
| Neurodevelopmental effects of fetal antiepileptic drug exposure | Q28080703 | ||
| Contemporary issues surrounding folic Acid fortification initiatives | Q28083544 | ||
| Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE) | Q28243974 | ||
| Effects of antiepileptic drug monotherapy on one-carbon metabolism and DNA methylation in patients with epilepsy | Q28546720 | ||
| Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age. | Q30498029 | ||
| Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study | Q30540714 | ||
| Emerging roles for folate and related B-vitamins in brain health across the lifecycle. | Q30867600 | ||
| Predicting language development at age 18 months: data from the Norwegian Mother and Child Cohort Study | Q33890859 | ||
| Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children | Q34035552 | ||
| IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study | Q35106308 | ||
| New Perspective on Impact of Folic Acid Supplementation during Pregnancy on Neurodevelopment/Autism in the Offspring Children - A Systematic Review | Q36201052 | ||
| Exposure to antiepileptic drugs in utero and child development: a prospective population-based study | Q37153982 | ||
| Folic acid supplements in pregnancy and severe language delay in children | Q37190519 | ||
| Use of folic acid supplements in early pregnancy in relation to maternal plasma levels in week 18 of pregnancy | Q37438395 | ||
| Toddlers with delayed expressive language: an overview of the characteristics, risk factors and language outcomes | Q38170946 | ||
| Identifying and managing common childhood language and speech impairments | Q38482020 | ||
| Management of developmental speech and language disorders: Part 1. | Q38553660 | ||
| Pharmacokinetic variability of valproate in women of childbearing age. | Q38612367 | ||
| Managing Epilepsy in Women | Q38722691 | ||
| Fetal antiepileptic drug exposure and cognitive outcomes | Q38804668 | ||
| Cognitive functions in children exposed to antiepileptic drugs in utero - Study in Georgia | Q40401690 | ||
| Changes in knowledge and attitudes of folate, and use of dietary supplements among women of reproductive age in Norway 1998-2000. | Q40482536 | ||
| Outcomes of early language delay: I. Predicting persistent and transient language difficulties at 3 and 4 years | Q40541020 | ||
| Self-selection and bias in a large prospective pregnancy cohort in Norway | Q43258883 | ||
| Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs. | Q43271402 | ||
| Pregnancy in women with epilepsy : preliminary results of Kerala registry of epilepsy and pregnancy. | Q43575658 | ||
| Effects of folic acid and lamotrigine therapy in some rodent models of epilepsy and behaviour | Q44424923 | ||
| Trajectories of language delay from age 3 to 5: persistence, recovery and late onset | Q45238229 | ||
| Liquid chromatography-tandem mass spectrometry analysis of folate and folate catabolites in human serum | Q46054745 | ||
| Association of Folic Acid Supplementation During Pregnancy With the Risk of Autistic Traits in Children Exposed to Antiepileptic Drugs In Utero | Q47569415 | ||
| Depression and anxiety in women with epilepsy during pregnancy and after delivery: a prospective population-based cohort study on frequency, risk factors, medication, and prognosis | Q47770489 | ||
| Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding: a prospective cohort study on children of women with epilepsy | Q48422568 | ||
| Cohort Profile Update: The Norwegian Mother and Child Cohort Study (MoBa). | Q50156784 | ||
| Pregnancy and epilepsy | Q50343582 | ||
| In utero exposure to levetiracetam vs valproate: development and language at 3 years of age. | Q50666853 | ||
| Language skills of school-aged children prenatally exposed to antiepileptic drugs. | Q51054642 | ||
| A validation study of the Norwegian version of the Ages and Stages Questionnaires. | Q51904340 | ||
| Measuring the mental health status of the Norwegian population: a comparison of the instruments SCL-25, SCL-10, SCL-5 and MHI-5 (SF-36). | Q51948768 | ||
| Intellectual and language functions in children of mothers with epilepsy. | Q51974875 | ||
| Revision of a Parent-Completed Developmental Screening Tool: Ages and Stages Questionnaires | Q52194272 | ||
| Early identification of language delay by direct language assessment or parent report? | Q53034693 | ||
| Antiepileptic drugs interact with folate and vitamin B12 serum levels | Q83234546 | ||
| Analytical recovery of folate degradation products formed in human serum and plasma at room temperature | Q83871929 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | folic acid | Q127060 |
| P304 | page(s) | e811-e821 | |
| P577 | publication date | 2018-08-28 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Verbal abilities in children of mothers with epilepsy: Association to maternal folate status | |
| P478 | volume | 91 |
| Q60920919 | Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Risk for Attention-Deficit/Hyperactivity Disorder in Offspring |
| Q92143979 | Developmental outcomes at age four following maternal antiepileptic drug use |
| Q92885250 | Epilepsy Benchmarks Area IV: Limit or Prevent Adverse Consequence of Seizures and Their Treatment Across the Life Span |
| Q91523062 | Maternal folate levels during pregnancy and children's neuropsychological development at 2 years of age |
| Q94572350 | Valproate and folate: Congenital and developmental risks |
Search more.